Department of Anesthesiology and Pain Medicine, College of Medicine, Eulji University Hospital, Daejeon 302-120, Korea.
Korean J Physiol Pharmacol. 2008 Aug;12(4):155-64. doi: 10.4196/kjpp.2008.12.4.155. Epub 2008 Aug 31.
Resveratrol has been known to possess various potent cardiovascular effects in animal, but there is little information on its functional effect on the secretion of catecholamines (CA) from the perfused model of the adrenal medulla. Therefore, the aim of the present study was to determine the effect of resveratrol on the CA secretion from the isolated perfused model of the normotensive rat adrenal gland, and to elucidate its mechanism of action. Resveratrol (10~100microM) during perfusion into an adrenal vein for 90 min inhibited the CA secretory responses evoked by ACh (5.32 mM), high K(+) (a direct membrane-depolarizer, 56 mM), DMPP (a selective neuronal nicotinic N(n) receptor agonist, 100microM) and McN-A-343 (a selective muscarinic M(1) receptor agonist, 100microM) in both a time- and dose-dependent fashion. Also, in the presence of resveratrol (30microM), the secretory responses of CA evoked by veratridine 8644 (an activator of voltage-dependent Na(+) channels, 100microM), Bay-K-8644 (a L-type dihydropyridine Ca(2+) channel activator, 10microM), and cyclopiazonic acid (a cytoplasmic Ca(2+)-ATPase inhibitor, 10microM) were significantly reduced. In the simultaneous presence of resveratrol (30microM) and L-NAME (an inhibitor of NO synthase, 30microM), the CA secretory evoked by ACh, high K(+) , DMPP, McN-A-343, Bay-K-8644 and cyclopiazonic acid were recovered to a considerable extent of the corresponding control secretion compared with the inhibitory effect of resveratrol alone. Interestingly, the amount of nitric oxide (NO) released from the adrenal medulla was greatly increased in comparison to its basal release. Taken together, these experimental results demonstrate that resveratrol can inhibit the CA secretory responses evoked by stimulation of cholinergic nicotinic receptors, as well as by direct membrane-depolarization in the isolated perfused model of the rat adrenal gland. It seems that this inhibitory effect of resveratrol is exerted by inhibiting an influx of both ions through Na(+) and Ca(2+) channels into the adrenomedullary cells as well as by blocking the release of Ca(2+) from the cytoplasmic calcium store, which are mediated at least partly by the increased NO production due to the activation of NO synthase.
白藜芦醇已被证实具有多种有效的心血管作用,在动物中,但关于其对去甲肾上腺素(CA)分泌的功能影响的信息很少。因此,本研究的目的是确定白藜芦醇对正常血压大鼠肾上腺分离灌流模型中 CA 分泌的影响,并阐明其作用机制。白藜芦醇(10~100μM)在 90 分钟的灌流过程中,对乙酰胆碱(5.32mM)、高 K+(直接膜去极化剂,56mM)、DMPP(选择性神经元烟碱 N(n)受体激动剂,100μM)和 McN-A-343(选择性毒蕈碱 M1 受体激动剂,100μM)诱导的 CA 分泌反应具有时间和剂量依赖性的抑制作用。此外,在存在白藜芦醇(30μM)的情况下,维拉帕米 8644(一种电压依赖性 Na+通道激活剂,100μM)、Bay-K-8644(一种 L 型二氢吡啶 Ca2+通道激活剂,10μM)和环匹阿尼酸(一种细胞质 Ca2+-ATP 酶抑制剂,10μM)诱导的 CA 分泌反应明显减少。在同时存在白藜芦醇(30μM)和 L-NAME(一种一氧化氮合酶抑制剂,30μM)的情况下,与白藜芦醇单独作用的抑制作用相比,乙酰胆碱、高 K+、DMPP、McN-A-343、Bay-K-8644 和环匹阿尼酸诱导的 CA 分泌反应恢复到相当大的程度。有趣的是,与基础释放相比,肾上腺髓质中释放的一氧化氮(NO)量大大增加。总之,这些实验结果表明,白藜芦醇可以抑制刺激胆碱能烟碱受体以及直接膜去极化引起的 CA 分泌反应。似乎这种白藜芦醇的抑制作用是通过抑制 Na+和 Ca2+通道流入肾上腺髓质细胞的离子流入以及通过阻止细胞质钙库中 Ca2+的释放来实现的,这至少部分是由于一氧化氮合酶的激活导致一氧化氮生成增加介导的。